Company Filing History:
Years Active: 2024
Title: Yinglin Gao - Innovator in Pulmonary Arterial Hypertension Treatment.
Introduction
Yinglin Gao is a notable inventor based in Upper Saddle River, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension (PAH). His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Yinglin Gao holds a patent for "Anti-PDGF-B antibodies and pharmaceutical composition thereof." This patent provides anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies and antigen-binding fragments. The methods described in the patent are aimed at treating subjects suffering from pulmonary arterial hypertension, showcasing Gao's commitment to advancing medical science.
Career Highlights
Gao is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development. His role at Regeneron allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical innovation.
Collaborations
Some of his notable coworkers include Scott Macdonnell and Bharathi Sundaram. Their collective expertise fosters a collaborative environment that drives innovation and research excellence.
Conclusion
Yinglin Gao's work in developing anti-PDGF-B antibodies represents a significant advancement in the treatment of pulmonary arterial hypertension. His contributions to Regeneron Pharmaceuticals and the medical field highlight the importance of innovation in addressing complex health issues.